[HTML][HTML] Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

S Bonazzi, E d'Hennezel, REJ Beckwith, L Xu… - Cell Chemical …, 2023 - cell.com
Malignant tumors can evade destruction by the immune system by attracting immune-
suppressive regulatory T cells (Treg) cells. The IKZF2 (Helios) transcription factor plays a …

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

S Bonazzi, E d'Hennezel, REJ Beckwith… - Cell chemical …, 2023 - pubmed.ncbi.nlm.nih.gov
Malignant tumors can evade destruction by the immune system by attracting immune-
suppressive regulatory T cells (Treg) cells. The IKZF2 (Helios) transcription factor plays a …

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.

S Bonazzi, E d'Hennezel, REJ Beckwith, L Xu… - Cell Chemical …, 2023 - europepmc.org
Malignant tumors can evade destruction by the immune system by attracting immune-
suppressive regulatory T cells (Treg) cells. The IKZF2 (Helios) transcription factor plays a …

[HTML][HTML] Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

S Bonazzi, E d'Hennezel, REJ Beckwith, L Xu… - Cell Chemical …, 2023 - cell.com
Malignant tumors can evade destruction by the immune system by attracting immune-
suppressive regulatory T cells (Treg) cells. The IKZF2 (Helios) transcription factor plays a …

[HTML][HTML] Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

S Bonazzi, E d'Hennezel, REJ Beckwith, L Xu… - Cell Chemical …, 2023 - Elsevier
Malignant tumors can evade destruction by the immune system by attracting immune-
suppressive regulatory T cells (Treg) cells. The IKZF2 (Helios) transcription factor plays a …